Sponsor

2015/12/02

Tune in for our webcast on antibody technologies


nature.com webcasts
Presented by

BioPharma Dealmakers

Join us for our upcoming webcast with live Q&A:
Developing next-generation antibody technologies


Date:
Wednesday, December 16, 2015
Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET

Register for free


Join us to explore the potential of next-generation antibody technologies. Learn about new approaches to improve antibody production and the development of antibody–drug conjugates (ADC) — specifically techniques that can:

  • Generate high-quality antibodies in large quantities.
  • Eliminate the formation of inclusion bodies in the antibody production.
  • Result in safer and more effective ADCs by attaching drugs to the naturally-occurring glycan anchor point, present on all antibodies.
  • Reduce ADC aggregation potential with a payload-enhancing linker technology.
SPEAKERS:  
Dr. Floris van Delft Dr. Phil Barish
 
Dr. Floris van Delft
Synaffix BV
Dr. Phil Barish
AbSci


MODERATOR:  
Gaspar Taroncher-Oldenburg, Ph.D.                                                          (CEO, Nanovelos)
Gaspar Taroncher-Oldenburg, Ph.D.

Gaspar has been the Chief Editor of BioPharma Dealmakers and is an independent consultant in the areas of translational research analysis, clinical outcomes evaluation, STEM publishing, crowdsourcing and open innovation.
   


Unable to join the live event? Watch on-demand. Register to receive information on how to gain access after the live event.


Register for free



BioPharma Dealmakers Webcasts are dedicated to small and large companies looking for commercial partnerships. Sign up for our e-alerts to read the quarterly BioPharma Dealmakers supplement in Nature Biotechnology and Nature Reviews Drug Discovery. receive latest updates on the partnering landscape, and access cutting edge editorials on burgeoning therapeutic areas.

Sponsored by:

OncoSec Adaptive Biotechnologies
 
As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails please unsubscribe here or to edit your Nature Publishing Group email services please click here to modify your account (Log in to be recognised as a Nature.com registrant).

For further information on technical assistance | print subscriptions | other enquiries.

Nature Publishing Group | Principal offices: London | New York and Tokyo and offices in cities worldwide including Basingstoke | Boston | Buenos Aires | Delhi | Madrid | Melbourne | Mexico City | Munich | Paris | San Francisco | Sao Paulo | Seoul | Shanghai and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | US

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.

No comments:

Post a Comment

Keep a civil tongue.

Label Cloud

Technology (1464) News (793) Military (646) Microsoft (542) Business (487) Software (394) Developer (382) Music (360) Books (357) Audio (316) Government (308) Security (300) Love (262) Apple (242) Storage (236) Dungeons and Dragons (228) Funny (209) Google (194) Cooking (187) Yahoo (186) Mobile (179) Adobe (177) Wishlist (159) AMD (155) Education (151) Drugs (145) Astrology (139) Local (137) Art (134) Investing (127) Shopping (124) Hardware (120) Movies (119) Sports (109) Neatorama (94) Blogger (93) Christian (67) Mozilla (61) Dictionary (59) Science (59) Entertainment (50) Jewelry (50) Pharmacy (50) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14)

Popular Posts (Last 7 Days)